Abstract:Purpose: Endothelial graft rejection is one of the most common causes of graft failure following penetrating keratoplasty (PK). The aim of this study was to evaluate the incidence, time course and outcome of treatment of graft rejection after normal-risk PK and to identify possible risk factors for the recurrence of immune reactions and irreversible graft failure. Patients and methods: The study included 500 eyes from the prospective Erlanger Normal-risk Keratoplasty Study with a mean follow-up of 42 +/- 18 (median 40) months. Indications for PK were keratoconus in 48 %, Fuchs' dystrophy in 30 %, secondary bullous keratopathy in 11 %, non-vascularized corneal scars in 7 % and stromal dystrophies in 4 %. Standardized complete ophthalmological examinations were performed on a regular basis before, during the acute graft rejection and then regularly in a defined examination raster in an cornea out-patient service. Results: During follow-up 29 eyes (5.6 %) developed an episode of endothelial graft rejection (23 eyes with acute diffuse and 6 eyes with chronic focal rejection type). Episodes of endothelial graft rejection clustered between 11 and 25 months postoperatively (15 from 29, 51.7 %). Most grafts (25 of 29) regained clarity after topical and systemic steroid treatment. Only 4 patients showed an irreversible graft failure requiring a repeat PK, all of whom had secondary bullous keratopathy as the primary indication for PK. Risk factors for irreversible graft failure were pre-existing anterior synechiae in 3 patients and secondary open angle glaucoma in pseudoexfoliation syndrome in one patient. Recurrence of graft rejection was seen in 5 patients (all with keratoconus) after a time interval of 8 to 12 months. Under very low topical steroid treatment no further recurrence was observed in all 5 patients up to 2 years. Conclusion: Patients should be followed-up on a regular base for longer postoperative periods, since most episodes of graft rejection were observed between 1 and 2 years after PK. Development of irreversible graft failure was strongly associated with pre-existing anterior synechiae and pre-existing glaucoma. Low-dose topical steroid treatment after immunological rejection seems to prevent the recurrence of further graft rejection.

Peripheral Ulcerative Keratitis: A Potential Blinding Eye Condition

Scleritis and peripheral ulcerative keratitis

Periphere ulzerative Keratitis: Klinik, Differenzialdiagnosen und TherapiekonzeptePeripheral Ulcerative Keratitis: Clinical Characteristics, Differential Diagnoses and Therapeutic Concepts

Demographic Characteristics, Clinical Presentations, and Risk Factors Impacting Visual Outcomes in Peripheral Ulcerative Keratitis

Management of simultaneous bilateral immune-mediated peripheral ulcerative keratitis

Peripheral Ulcerative Keratitis Associated With Large Vessel Vasculitis

Characteristics, Etiologies, and Outcomes of Peripheral Ulcerative Keratitis in a Tertiary Referral Hospital in Thailand: A 10-Year Study

Peripheral ulcerative keratitis in a patient with granulomatous rosacea

Indications and Outcomes of Penetrating Keratoplasty in a Tertiary Hospital in the Developing World

Coexistence of severe peripheral ulcerative keratitis and lichen planus: case report

Enhanced Surgical Safety through Protective Penetrating Keratoplasty: A Retrospective Analysis of 22 Cases

Post-keratoplasty Infectious Keratitis: Epidemiology, Risk Factors, Management, and Outcomes

Update on peripheral ulcerative keratitis

Optical Penetrating Keratoplasty in Eyes with Severe Keratomycosis after Therapeutic Keratoplasty

Risk Factors of Urrets-Zavalia Syndrome after Penetrating Keratoplasty

Diagnosing Paraproteinemic Keratopathy: A Case Report

Punctate inner choroidopathy: A review of the current diagnostic and therapeutic approaches

Infectious keratitis: A review

Bilateral Fuchs' Superficial Marginal Keratitis Diagnosis and Treatment

[Clinical aspects and treatment of immune reactions following penetrating normal-risk keratoplasty]

Keratopathy in Pseudoexfoliation syndrome